Posaconazole (PSZ) is a BCS (biopharmaceutical classification system) Class II anti-fungal drug used to treat infections in immunocompromised patients. The work presented herein describes the generation of cocrystals of PSZ with 4-aminobenzoic acid (4AMB) using supercritical CO2 as an antisolvent in GAS (Gas Antisolvent) with acetonitrile, and as a solvent in CSS (Cocrystallization with Supercritical Solvent) methods. Cocrystals of PSZ-4AMB were obtained in a 2:3 stoichiometric ratio for the first time by GAS and CSS methods, with GAS producing higher-purity samples compared to CSS method. The work presented herein investigates the influence of critical processing variables using CO2 solvent and antisolvent crystallization methods with respect to the formation of cocrystals of PSZ-4AMB. A Design of Experiments (DoE) approach was performed to assess the outcome of PSZ-4AMB formation, impacted by processing variables such as pressure, temperature, and stirring rate using GAS and CSS methods. The resulting cocrystalline phase was identified using differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD). The particle morphologies and size distributions were determined using scanning electron microscopy and automated static imaging, respectively.
History
Publication
The Journal of Supercritical Fluids;170, 105134
Publisher
Elsevier
Note
peer-reviewed
The full text of this article will not be available in ULIR until the embargo expires on the 13/12/2022
Other Funding information
SFI, EI, ERDF, European Union (EU)
Rights
This is the author’s version of a work that was accepted for publication in The Journal of Supercritical Fluids. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in The Journal of Supercritical Fluids, 2021, 170, 105134, https://doi.org/10.1016/j.supflu.2020.105134